During the past decade, CH de Dax conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 2 clinical trials were completed, i.e. on average, 5.9% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 2 clinical trials were completed. i.e. 10.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CH de Dax" #1 sponsor was "Intergroupe Francophone de Cancerologie Thoracique" with 10 trials, followed by "University Hospital, Bordeaux" with 7 trials sponsored, "Centre Hospitalier Régional d'Orléans" with 4 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 4 trials sponsored and "Ch Mont de Marsan" with 4 trials sponsored. Other sponsors include 31 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CH de Dax" #1 collaborator was "Biomet France SARL" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Association Clinique Thérapeutique Infantile du val de Marne" with 1 trials as a collaborator and "Aventis Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "CH de Dax" are "Breast Cancer" (4 trials), "Carcinoma, Non-Small-Cell Lung" (4 trials), "Colorectal Cancer" (4 trials), "Lymphoma" (4 trials) and "Ovarian Cancer" (4 trials). Many other conditions were trialed in "CH de Dax" in a lesser frequency.

Most popular intervention types in "CH de Dax" are "Drug" (19 trials), "Other" (16 trials), "Procedure" (8 trials), "Biological" (6 trials) and "Device" (5 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (4 trials), "gemcitabine hydrochloride" (3 trials), "Gemcitabine" (2 trials), "Pemetrexed" (2 trials) and "adjuvant therapy" (2 trials). Other intervention names were less common.

The vast majority of trials in "CH de Dax" are 57 trials for "All" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "CH de Dax". 1 are not yet recruiting, 11 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 41 completed trials in CH de Dax, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in CH de Dax, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 12 trials that are defined as “Not Applicable".

CH de Dax has several departments that took part in Clinical trials: "Ch De Dax; Radiotherapie Oncologie" - 3 trials